Yuncheng Technology

About

Based in China, Yuncheng Technology specializes in advanced data and AI-driven solutions tailored for the life sciences and healthcare sectors, enhancing operational efficiencies for pharmaceutical companies.Yuncheng Technology, established in 2016 in Hangzhou, China, focuses on providing innovative data and AI solutions for the healthcare industry. The company has successfully completed one notable deal as of May 27, 2026. The founder's background, including prior ventures, is not publicly documented.Yuncheng Technology provides advanced data and AI-driven solutions specifically designed for the life sciences and healthcare sectors. Their core product offerings include the Wu Kong 3.0 data business platform, delivering comprehensive cloud solutions for large pharmaceutical corporations, covering critical areas such as production, clinical trials, and marketing. The company’s products encompass pharmaceutical master data solutions, flow tracking products, and a leading industry database integrating AI and data applications. They serve multinational pharmaceutical giants like Novartis, Bayer, Eli Lilly, Takeda, and Johnson & Johnson, as well as domestic firms such as Hengrui Medicine and Qilu Pharmaceutical, primarily in China while also expanding into international markets.Yuncheng Technology's revenue model is based on subscription services and partnerships with pharmaceutical companies, primarily through B2B agreements. Clients subscribe to their cloud-based solutions and data management systems, providing a recurring revenue stream. The Wu Kong data platform is offered under various pricing plans tailored to client needs, though specific pricing details are not disclosed. Revenue is also generated from additional services including data collection, cleansing, and management systems.In May 2026, Yuncheng Technology raised an undisclosed amount of Series A funding led by Gobi Partners. This financing will support their strategy to expand market share in the Internet big data industry while enhancing technological strength and service capabilities. The company plans to introduce new products and services in the near future, although specific release dates have not been provided. They aim to penetrate new markets, both domestically and internationally, although targeted regions have not been specified.